122 related articles for article (PubMed ID: 15508524)
1. Bystander cells and prognosis in Hodgkin lymphoma. Review based on a doctoral thesis.
Molin D
Ups J Med Sci; 2004; 109(3):179-228. PubMed ID: 15508524
[TBL] [Abstract][Full Text] [Related]
2. Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma.
Molin D; Edström A; Glimelius I; Glimelius B; Nilsson G; Sundström C; Enblad G
Br J Haematol; 2002 Oct; 119(1):122-4. PubMed ID: 12358914
[TBL] [Abstract][Full Text] [Related]
3. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.
Molin D; Fischer M; Xiang Z; Larsson U; Harvima I; Venge P; Nilsson K; Sundström C; Enblad G; Nilsson G
Br J Haematol; 2001 Sep; 114(3):616-23. PubMed ID: 11552987
[TBL] [Abstract][Full Text] [Related]
4. Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's lymphoma--a population-based study.
Glimelius I; Rubin J; Rostgaard K; Amini RM; Simonsson M; Sorensen KM; Smedby KE; Venge P; Hjalgrim H; Molin D; Enblad G
Eur J Haematol; 2011 Sep; 87(3):208-16. PubMed ID: 21623917
[TBL] [Abstract][Full Text] [Related]
5. The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.
Molin D; Glimelius B; Sundström C; Venge P; Enblad G
Leuk Lymphoma; 2001 Jul; 42(3):457-65. PubMed ID: 11699410
[TBL] [Abstract][Full Text] [Related]
6. The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children.
Englund A; Molin D; Enblad G; Karlén J; Glimelius I; Ljungman G; Amini RM
Eur J Haematol; 2016 Nov; 97(5):430-438. PubMed ID: 26872637
[TBL] [Abstract][Full Text] [Related]
7. IL-9 expression contributes to the cellular composition in Hodgkin lymphoma.
Glimelius I; Edström A; Amini RM; Fischer M; Nilsson G; Sundström C; Enblad G; Molin D
Eur J Haematol; 2006 Apr; 76(4):278-83. PubMed ID: 16519698
[TBL] [Abstract][Full Text] [Related]
8. Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue.
Fischer M; Juremalm M; Olsson N; Backlin C; Sundström C; Nilsson K; Enblad G; Nilsson G
Int J Cancer; 2003 Nov; 107(2):197-201. PubMed ID: 12949794
[TBL] [Abstract][Full Text] [Related]
9. Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines.
Glimelius I; Rubin J; Fischer M; Molin D; Amini RM; Venge P; Enblad G
Exp Hematol; 2011 Aug; 39(8):850-8. PubMed ID: 21679745
[TBL] [Abstract][Full Text] [Related]
10. Standard therapies versus novel therapies in Hodgkin lymphoma.
Gallamini A; Di Raimondo F; La Nasa G; Romano A; Borra A; Greco M
Immunol Lett; 2013; 155(1-2):56-9. PubMed ID: 24140162
[TBL] [Abstract][Full Text] [Related]
11. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line.
Pinto A; Aldinucci D; Gloghini A; Zagonel V; Degan M; Improta S; Juzbasic S; Todesco M; Perin V; Gattei V; Herrmann F; Gruss HJ; Carbone A
Blood; 1996 Nov; 88(9):3299-305. PubMed ID: 8896393
[TBL] [Abstract][Full Text] [Related]
12. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.
Gruss HJ; Pinto A; Gloghini A; Wehnes E; Wright B; Boiani N; Aldinucci D; Gattei V; Zagonel V; Smith CA; Kadin ME; von Schilling C; Goodwin RG; Herrmann F; Carbone A
Am J Pathol; 1996 Aug; 149(2):469-81. PubMed ID: 8701986
[TBL] [Abstract][Full Text] [Related]
13. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
Gruss H-J ; Herrmann F
Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
[TBL] [Abstract][Full Text] [Related]
14. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
Andersen MD; Kamper P; Nielsen PS; Bendix K; Riber-Hansen R; Steiniche T; Hamilton-Dutoit S; Clausen M; d'Amore F
Eur J Haematol; 2016 Mar; 96(3):252-9. PubMed ID: 25963595
[TBL] [Abstract][Full Text] [Related]
15. CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro.
Hansen HP; Trad A; Dams M; Zigrino P; Moss M; Tator M; Schön G; Grenzi PC; Bachurski D; Aquino B; Dürkop H; Reiners KS; von Bergwelt-Baildon M; Hallek M; Grötzinger J; Engert A; Paes Leme AF; Pogge von Strandmann E
Oncotarget; 2016 May; 7(21):30523-35. PubMed ID: 27105521
[TBL] [Abstract][Full Text] [Related]
16. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.
Dürkop H; Hirsch B; Hahn C; Foss HD; Stein H
J Pathol; 2003 Jun; 200(2):229-39. PubMed ID: 12754742
[TBL] [Abstract][Full Text] [Related]
17. Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma.
Uchihara JN; Matsuda T; Okudaira T; Ishikawa C; Masuda M; Horie R; Watanabe T; Ohta T; Takasu N; Mori N
Int J Cancer; 2006 Mar; 118(5):1098-107. PubMed ID: 16152613
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
[TBL] [Abstract][Full Text] [Related]
19. Lymphomagenesis in Hodgkin lymphoma.
Matsuki E; Younes A
Semin Cancer Biol; 2015 Oct; 34():14-21. PubMed ID: 25725205
[TBL] [Abstract][Full Text] [Related]
20. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
